NCT05690828 (e-ONCOGITE) is a NA clinical trial of Cognitive remediation in Breast Cancer, sponsored by Institut Bergonié.

Who is sponsoring NCT05690828?

NCT05690828 is sponsored by Institut Bergonié.

What drugs are being tested in NCT05690828?

Interventions in NCT05690828: Cognitive remediation.

What condition does NCT05690828 study?

NCT05690828 studies Breast Cancer.

Is NCT05690828 still recruiting?

NCT05690828 is currently active, enrolled. Last updated 13 August 2025.

Last reviewed 2025-08-13 · How we verify

NCT05690828: e-ONCOGITE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.

Active, enrolled NA Last updated 13 August 2025

What this trial tests

NA trial testing Cognitive remediation in Breast Cancer in 164 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 February 2023

Primary endpoint
30 October 2024

31 March 2026

Quick facts

Lead sponsor	Institut Bergonié
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	164
Start date	1 February 2023
Primary completion	30 October 2024
Estimated completion	31 March 2026
Sites	1 location across France

Drugs / interventions tested

Cognitive remediation — full drug profile →

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Institut Bergonié — full company profile →

Who can join

Adults 20 to 60, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will investigate the efficacy of a cognitive remediation programme in patients treated for breast cancer. patients will be randomized between "no intervention" and "intervention programme". Efficay will be assessed in term of improved quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cognitive remediation

Trials testing the same drug.

NCT05661448 — Promoting Cognitive Health in Schizophrenia · NA · recruiting
NCT04033978 — Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia · NA · terminated
NCT03311880 — Evaluating a Cognitive Remediation Intervention for Women During the Menopausal Transition · NA · completed
NCT03268434 — Evaluation of Metacognitive Training for Depression (D-MCT) in Outpatient Care · NA · completed

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Institut Bergonié trials

Trials by the same sponsor.

NCT06084689 — Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures · Phase 2 · withdrawn
NCT06700057 — Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. · recruiting
NCT05415527 — Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Mana · NA · active not recruiting
NCT04912687 — Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients · NA · completed
NCT05070897 — Health Literacy and Digital Health in Cancer Patients. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05690828 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Bergonié
Last refreshed: 13 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing